This was confirmed in a study by Hosaka et al., where VASH-1 was restricted to endothelial cells and its expression correlated with the expression of VEGF, FGF-2 (basic fibroblast growth factor 2), and HIF-1α (hypoxia-inducible factor 1 alpha) in tumor cells. This evidence concerns the gene HIF1A and neoplasm.